SIRT1 in the Development and Treatment of Hepatocellular Carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

SIRT1 in the Development and Treatment of Hepatocellular Carcinoma

Published:2019-09-25 Issue: Volume:6 Page:
ISSN:2296-861X
Container-title:Frontiers in Nutrition
language:
Short-container-title:Front. Nutr.

Author:

Farcas Marius,Gavrea Andrei-Alexandru,Gulei Diana,Ionescu Calin,Irimie Alexandru,Catana Cristina S.,Berindan-Neagoe Ioana

Publisher

Frontiers Media SA

Subject

Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism,Food Science

Reference255 articles.

1. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005;Altekruse;J Clin Oncol,2009

2. Epidemiology of viral hepatitis and hepatocellular carcinoma;El-Serag;Gastroenterology,2012

3. Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis;Gomaa;World J Gastroenterol,2008

4. Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review;White;Clin Gastroenterol Hepatol.,2012

5. Obesity and diabetes as a risk factor for hepatocellular carcinoma;Regimbeau;Liver Transplant,2004

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging targets in amyotrophic lateral sclerosis (ALS): The promise of ATP-binding cassette (ABC) transporter modulation;Behavioural Brain Research;2025-01

2. Targeting Hepatic Cancer Stem Cells (CSCs) and Related Drug Resistance by Small Interfering RNA (siRNA);Cell Biochemistry and Biophysics;2024-07-26

3. The dual role of sirtuins in cancer: biological functions and implications;Frontiers in Oncology;2024-06-14

4. Non-coding RNA transcripts, incredible modulators of cisplatin chemo-resistance in bladder cancer through operating a broad spectrum of cellular processes and signaling mechanism;Non-coding RNA Research;2024-06

5. Role of sirtuin 1 (SIRT1) in regulation of autophagy and nuclear factor-kappa Beta (NF-ĸβ) pathways in sorafenib-resistant hepatocellular carcinoma (HCC);Cell Biochemistry and Biophysics;2024-03-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3